- Home
- SONN vs GIFT Comparison
SONN vs GIFT Comparison
Compare SONN & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- GIFT
- Stock Information
- Founded
- SONN N/A
- GIFT 1999
- Country
- SONN United States
- GIFT United States
- Employees
- SONN N/A
- GIFT N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- GIFT Catalog/Specialty Distribution
- Sector
- SONN Health Care
- GIFT Consumer Discretionary
- Exchange
- SONN Nasdaq
- GIFT Nasdaq
- Market Cap
- SONN 32.4M
- GIFT 33.9M
- IPO Year
- SONN N/A
- GIFT N/A
- Fundamental
- Price
- SONN $3.20
- GIFT $1.08
- Analyst Decision
- SONN Strong Buy
- GIFT Strong Buy
- Analyst Count
- SONN 1
- GIFT 1
- Target Price
- SONN $20.00
- GIFT $4.00
- AVG Volume (30 Days)
- SONN 503.8K
- GIFT 116.1K
- Earning Date
- SONN 12-16-2025
- GIFT 11-13-2025
- Dividend Yield
- SONN N/A
- GIFT N/A
- EPS Growth
- SONN N/A
- GIFT N/A
- EPS
- SONN N/A
- GIFT N/A
- Revenue
- SONN $1,000,000.00
- GIFT $90,569,384.00
- Revenue This Year
- SONN $5,376.22
- GIFT $5.90
- Revenue Next Year
- SONN N/A
- GIFT $13.45
- P/E Ratio
- SONN N/A
- GIFT N/A
- Revenue Growth
- SONN 1689.52
- GIFT 8.55
- 52 Week Low
- SONN $1.08
- GIFT $0.82
- 52 Week High
- SONN $19.30
- GIFT $2.38
- Technical
- Relative Strength Index (RSI)
- SONN 38.92
- GIFT 43.62
- Support Level
- SONN $4.42
- GIFT $1.10
- Resistance Level
- SONN $5.15
- GIFT $1.18
- Average True Range (ATR)
- SONN 0.63
- GIFT 0.08
- MACD
- SONN -0.07
- GIFT -0.00
- Stochastic Oscillator
- SONN 2.93
- GIFT 11.63
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.